IP Verse

Neurim Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Neurim Pharmaceuticals opposed by its competitors

Explore Neurim Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3103443
Jun 30, 2021Method For Treating Primary Insomnia7
EP1441702
May 10, 2017Method For Treating Primary Insomnia4

Latest publications and patents of Neurim Pharmaceuticals New

Explore the latest publications and patents granted to Neurim Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Neurim Pharmaceuticals

EP3103443
Jun 30, 2021Method For Treating Primary InsomniaGranted And Under Opposition
EP1441702
May 10, 2017Method For Treating Primary InsomniaRevoked

Latest PTAB cases involving Neurim Pharmaceuticals

Discover the latest PTAB cases involving Neurim Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Neurim Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NEURIM PHARMACEUTICALS - 11 - -
GENERICS UK214 - - -
HAMM & WITTKOPP112 - - -
ORIFARM GENERICS2 - - -